series-b
Stage
2
Investors
About
Pathalys is a private, late-stage clinical biopharmaceutical company focused on developing advanced therapeutics for patients with chronic kidney disease, particularly secondary hyperparathyroidism in end-stage kidney disease.
Explore Pathalys's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.